Breanna Olson, who has ALS, used an EEG headset from Dentsu Lab and NTT to control a mixed‑reality avatar live on stage in Amsterdam in December. The Waves of Will project tests non‑invasive brain–computer control to restore personal expression for people with motor‑degenerative conditions.
Read moreMen’s Journal tested sleep wearables and named the Somnee Smart Sleep Headband its top active sleep tracker on Apr 7, 2026, citing EEG-based tracking and pre‑bed neurostimulation but noting comfort and data‑reliability issues.
Read moreMIT.nano enrolled 16 startups into its START.nano program in 2025, expanding the accelerator to more than 32 companies. The cohort spans health, semiconductors, quantum hardware and includes Cahira Technologies, a developer of nonsurgical neural implants.
Read moreA poster at Cedars-Sinai’s vMed described AlphaRise, a 2D EEG-based neurofeedback game for people with MS that classifies five brain states, runs 5-minute sessions, and includes a Compassionate Mode to accommodate fatigue.
Read moreMindset Technologies, founded in 2024 in Burgenland, announced on 7 April 2026 its Enhanced Pilot Performance System (EPPS), a wearable neurotech device that measures pilots' cognitive load in real time. The company said it won a Defence Conference hackathon and was supported by the Wirtschaftsagentur Burgenland incubator.
Read moreZurich NeuroTech startup Connectome Health raised $2 million pre-seed to build a longitudinal platform that creates personalised cognitive baselines, applying methods from Imperial College London’s LUCID study and linking neural signals to sleep and activity.
Read moreFinnish neurotech Audicin raised $1.9M, taking its total to about $3M, to expand its audio-based app, sleep headband and a lightweight SDK for embedding nervous-system regulation into other platforms.
Read moreEpia Neuro announced an implanted read/write BCI platform for stroke survivors that pairs a skull-mounted device with AI and a grip-assist prosthetic; first-in-human demonstrations are planned for later in 2026 at Lenox Hill Hospital.
Read moreDevelopers unveiled a wearable that they say uses machine learning and advanced sensors to generate a real-time fatigue score. Public validation data and regulatory status were not disclosed, so independent review is still needed.
Read moreShanghai-based StairMed closed RMB 500 million (~$72.8M) in a round led by Alibaba with participation from Tencent and other investors, bringing the company’s funding to over RMB 1.1 billion in the past year and targeting mid-2026 large-scale clinical development.
Read moreWhoop raised $575 million at a $10.1 billion valuation in a round led by Collaborative Fund, with participation from the Qatar Investment Authority and athletes LeBron James and Cristiano Ronaldo. The company makes a 24/7 wristband that tracks HRV, blood pressure and blood oxygen and has shifted from an elite-athlete focus toward broader consumer health.
Read moreThe Business Research Company forecasts the closed-loop neuromodulation processor market will reach $4.63 billion by 2030 (12.9% CAGR), citing AI-driven adaptive processors, wearable controllers and telemedicine integration; the report also highlights Medtronic's Feb 2025 FDA approvals and a 2023 Amber–Bioinduction acquisition.
Read moreParadromics launched an APEX Partnership Program to connect academic BCI researchers with its Connexus implantable interface; the FDA-approved Connect-One study aims to begin the first surgery in H1 2026.
Read moreCognito Therapeutics has joined Ochsner Health to pilot its investigational Spectris system—gamma-frequency light and sound neuromodulation—across the Gulf South, aiming to develop a Brain Health Index and gather real-world clinical and health-economics data.
Read moreEMOTIV has published an Ubuntu beta of its Launcher app, providing a single-login hub for EMOTIV EEG headsets and apps with raw-data capture, BCI controls, device management, and a Virtual Brainwear simulator.
Read moreAvation Medical appoints co-founder Manish Vaishya, PhD as CEO and closes Series D financing to scale commercialization and reimbursement for its FDA-cleared Vivally wearable neuromodulation system for overactive bladder.
Read more